Premium
Solitary pituitary metastasis from HER2 ‐positive breast cancer
Author(s) -
Kam Jeremy,
Kam Jeffrey,
Mann G Bruce,
Phillips Claire,
Wentworth John M,
King James,
Lindeman Geoffrey J
Publication year - 2017
Publication title -
asia‐pacific journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 29
eISSN - 1743-7563
pISSN - 1743-7555
DOI - 10.1111/ajco.12353
Subject(s) - trastuzumab , metastasis , breast cancer metastasis , breast cancer , medicine , oncology , brain metastasis , breast carcinoma , disease , cancer , cancer research , cancer metastasis
The introduction of anti‐ HER2 therapy with trastuzumab has seen an increase in frequency of central nervous system metastasis as the site of first recurrence. Here, we present a rare case of a 63‐year‐old woman who presented with an isolated breast carcinoma pituitary metastasis 5 years following treatment for a high‐risk breast cancer. This report underscores the changing nature of HER2 ‐positive disease in the post‐trastuzumab era.